|
| Dabigatran iMpurity F Basic information |
Product Name: | Dabigatran iMpurity F | Synonyms: | Dabigatran etexilate impurity180;Ethyl 3-(1-methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate (Dabigatran Impurity);β-Alanine, N-[(2,3-dihydro-1-methyl-2-oxo-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-, ethyl ester;Dabigatran Etexilate Impurity 29;Dabigatran etexilate-11;Dabigatran impurity 32/Ethyl 3-(1-Methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate;Dabigatran impurity 29;Dabigatran ester impurity J | CAS: | 1642853-67-5 | MF: | C19H20N4O4 | MW: | 368.39 | EINECS: | | Product Categories: | benzimidazol;Dabigatran impurity | Mol File: | 1642853-67-5.mol | |
| Dabigatran iMpurity F Chemical Properties |
density | 1.305±0.06 g/cm3(Predicted) | pka | 11.69±0.30(Predicted) |
| Dabigatran iMpurity F Usage And Synthesis |
Uses | Ethyl 3-(1-Methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate is an impurity of Dabigatran (D100090), a nonpeptide, direct thrombin inhibitor. Antithrombotic. |
| Dabigatran iMpurity F Preparation Products And Raw materials |
|